Ponatinib in refractory Philadelphia chromosome-positive leukemias.
Cortes JE; Kantarjian H; Shah NP; Bixby D; Mauro MJ; Flinn I; O'Hare T; Hu S; Narasimhan NI; Rivera VM; Clackson T; Turner CD; Haluska FG; Druker BJ; Deininger MW; Talpaz M; The New England Journal Of Medicine, 2012, vol. 367, issue 22, p 2075, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation